Xenna Corporation develops and distributes personal care products for nails, skin and hair. Its brands include:

NonyX^® Nail Gel
CalleX^® Dry Heel Ointment
Curlaway^™ Curl Relaxer

CEO: Carol J. Buck, MIA, Columbia University; BA, Stanford University.

Prior to founding Xenna, Ms. Buck was the Vice President of Princeton Group International, Inc., a healthcare industry consulting firm. Among her clients were Beth Israel Hospital, Ethicon (J&J), David Sarnoff Research Center, Cyanotech Corporation, Biofem, Inc., Ixion Biotechnology, North Shore University Health System and Universal Health Communications. She was also Treasurer and a Board member of Atlantic Health, Inc., a firm established to build and operate outpatient cancer clinics worldwide. Earlier in her career, Ms. Buck was a Senior Product Manager at General Foods Corporation and an Account Supervisor within the advertising industry. In the early '90s Ms. Buck turned her focus to biochemistry and initiated the research and patents that form the framework for Xenna's personal care product lines and basic research. Ms. Buck is also a member of the Women Presidents' Organization.

Ms. Gordon manages the accounting and tax functions of the Company. She has 16 years of accounting and taxation experience with public accounting firms located in central New Jersey.

Ms. Bissell oversees wholesale, retail, physician and internet sales. Ms. Bissell has over 15
years of consumer product sales management and finance experience.

Edward S. Neiss, M.D., Ph.D; Bruce Bitcover, D.P.M.; Robert L. Vessella, Ph.D; Anjan K. Bhattacharyya, Ph.D; Gregg Fields, Ph.D.